E
Bio Essence Corporation BIOE
$0.23 $0.0188.49% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- 171.96% -13.49% -83.94% --
Total Other Revenue -- -- -- -- --
Total Revenue -- 171.96% -13.49% -83.94% --
Cost of Revenue -- -- -60.37% -91.66% --
Gross Profit -- -- 300.99% -73.38% --
SG&A Expenses 48.68% 126.93% -38.11% -42.27% 524.69%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 49.74% 121.52% -44.09% -47.36% 524.69%
Operating Income -35.11% -98.46% 57.82% 5.47% -524.69%
Income Before Tax -67.32% -112.77% -281.04% 23.60% -432.47%
Income Tax Expenses -- 100.00% -- -75.00% --
Earnings from Continuing Operations -67.32% -112.67% -281.04% 24.18% -432.47%
Earnings from Discontinued Operations -- 100.00% -- -- 264.89%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -253.70% 85.75% -281.04% 24.18% 174.89%
EBIT -35.11% -98.46% 57.82% 5.47% -524.69%
EBITDA -35.49% -98.16% 55.74% -1.66% -594.04%
EPS Basic -254.29% 89.23% -280.72% 30.49% 164.81%
Normalized Basic EPS -70.00% -120.00% 42.86% 31.37% -400.00%
EPS Diluted -254.29% 89.23% -280.72% 30.49% 164.81%
Normalized Diluted EPS -70.00% -120.00% 42.86% 31.37% -400.00%
Average Basic Shares Outstanding 0.00% 11.94% 0.00% 9.50% 15.15%
Average Diluted Shares Outstanding 0.00% 11.94% 0.00% 9.50% 15.15%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --